Beyond its impressive reach, Twitter has furthermore created an unprecedented opportunity to influence highly targeted pockets of conversations. It thus provides pharma with the unique chance to demonstrate that it …
Great news, we've signed you up.
Sorry, we weren't able to sign you up. Please check your details, and try again.
MS patient meets German clinical trial
Becoming a "patient-like-me" in EU
© 2012 whydot pharma
Powered by WordPress. Repro Theme by Orman Clark